Trial Profile
Phase I study of benzhydrocodone [KemPharm] in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Mar 2023
Price :
$35
*
At a glance
- Drugs Benzhydrocodone (Primary) ; Hydrocodone/paracetamol
- Indications Acute pain
- Focus Pharmacokinetics; Registrational
- 22 Feb 2023 According to a KemPharm media release, KemPharm has changed its name to Zevra Therapeutics.
- 19 Nov 2012 Based on results of this trial, KemPharm receives positive feedback from the US FDA on further clinical studies required for the approval of KP 201 under the 505(b)(2) regulatory pathway, according to a company media release.
- 22 May 2012 Status changed from recruiting to completed, according to a KemPharm media release.